Semaglutide is a glucagon-like peptide-1
receptor agonist. It is an antidiabetic medication used for the treatment of
type 2 diabetes and an anti-obesity medication used for long-term weight management.
Semaglutide is not for use in people with type 1 diabetes. Semaglutide is
indicated as an adjunct to diet and exercise to improve glycemic control in
patients. The higher-dose formulation of Semaglutide is indicated as an adjunct
to diet and exercise for long-term weight management in adults with obesity
(initial body mass index (BMI) ≥ 30 kg/m2) or who are overweight (initial BMI ≥
27 kg/m2) and have at least one weight-related comorbidity.
Effects:
– Weight loss up to 8 kg in 3 months
– Suppresses appetite
– Improved metabolism
– Stabilizes blood sugar levels
– Reduces inflammation, improves recovery
